Home›People›Errik Anderson
Errik Anderson

Errik Anderson

Director at Aakha Biologics. Also a founder, CEO, chairman of alloy at Alloy Therapeutics and a director at Angiex.

ExecutiveDirectorPublic companyRoles at 3 startups
Updated Nov 10, 2026·Latest SEC filing Apr 15, 2026·Suggest an edit

About Errik Anderson

Form D filings for Aakha Biologics in 2024 list Errik Anderson as director.

Form D filings also name Errik Anderson as a founder, CEO, chairman of alloy at Alloy Therapeutics and a director at Angiex.

Errik Anderson reports to the SEC as a major shareholder of 1 public company: Compass Therapeutics (CMPX).

Errik Anderson first appears on SEC filings in 2020.

Experience

This experience comes from Errik Anderson's profile and from SEC filings. For roles taken from filings, the years are when the filings name Errik Anderson in the role, so the role may have started earlier or lasted longer.

Aakha Biologics, Inc. Current
Director
2021 – Present · Frisco, TX
New England Free Jacks Current
Co-Founder, Owner
2018 – Present
WelbeHealth Current
Advisor, Former Board Member, Investor
2018 – Present
Major League Rugby Current
Board of Governors
2018 – Present
Alloy Therapeutics, Inc. Current
Founder, CEO, Chairman of Alloy
CEO, Chairman, Founder (2017 – Present)
2017 – Present · Waltham, MA
Drug discovery platforms and development services for biotech companies, pharmaceutical firms and academic researchers.
82VS Current
Managing Partner
2017 – Present
Alumni Ventures Current
Director, Investor
2014 – Present
Compass Therapeutics, Inc. Current
10% owner
Co-Founder (2013 – Present)
2013 – Present · Public company (CMPX)
Alector Current
Co-Founder
2013 – Present
Avitide, Inc. Current
Co-Founder, former Board Member
2012 – Present
Ulysses Diversified Holdings Current
Founder, Managing Partner
2010 – Present
Arsanis Current
Co-Founder, Former Board Member
2010 – Present
Adimab, LLC Current
Co-Founder
2007 – Present
Angiex, Inc.
Director
2025 · Cambridge, MA
Bristol-Myers Squibb Company
Summer Associate, Abilify US Marketing
2006
Lehman Brothers Venture Capital
Analyst
2000 – 2003

Key Colleagues at Startups

The people Errik Anderson works with at each company, as listed on that company's latest Form D.

Alloy Therapeutics, Inc. · Form D, Apr 15, 2026
AS
Anthony Sun
Director
AH
Alaa Halawa
Director
UN
JC
Jason Camm
Director
JC
Jason Coloma
Director
AK
Piotr Bobrowicz
Piotr Bobrowicz
Chief Scientific Advisor and director
LS
Logan Snyder
Director
Angiex, Inc. · Form D/A, Sep 26, 2025
JA
JC
Jason Camm
Director
FH
PJ
Paul Jaminet
Chief Executive Officer and director
AA
Amal Amin
Director
HG
Haijing Guo
Director
ID
Iain Dukes
Director
TN
Tina Neel
Director
Aakha Biologics, Inc. · Form D, Jul 17, 2024
HB
Hemanta Baruah
President and director

Sources

  1. SECAlloy Therapeutics, Inc. Form D, filed Apr 15, 2026
  2. SECAngiex, Inc. Form D/A, filed Sep 26, 2025
  3. SECAakha Biologics, Inc. Form D, filed Jul 17, 2024
  4. SECForms 3, 4 and 5 filed by Errik Anderson (SEC filer 1816338)